|
|
|
 |
|
 |
 |
|||
Company News
|
Zogenix Secures $35 Million Debt Facility And Raises $15 Million Investment Capita
San Diego, 13 July 2010
- Zogenix, Inc. (“Zogenix”), a privately held pharmaceutical company, announced that it has secured a $35 million debt facility led by Oxford Finance Corporation which also included Silicon Valley Bank. The facility consists of a $25 million term loan and a $10 million revolving line of credit. Concurrently, all existing Zogenix investors, including Clarus Ventures, Domain Associates, Scale Venture Partners, Thomas, McNerney & Partners, Abingworth Management, and Chicago Growth Partners, have provided an additional $15 million investment.
top
Infinity and Intellikine enter agreement to develop oral therapies targeting PI3 kinase delta, gamma
Cambridge, MA and La Jolla, CA, 08 July 2010
top
Abingworth makes Growth Equity Investment in Secure EDI
Commits up to $40m to support recapitalisation and growth
London, 05 May 2010
top
Abingworth wins Private Equity Award
London, 27 April 2010
top
Micromet Closes $80.5 Million Public Offering of Common Stock
Bethesa, Maryland, 17 March 2010
top
ABLYNX SUCCESSFULLY RAISES €50 MILLION WITH SECONDARY PUBLIC OFFERING
FINAL PRICE: €7.5 PER SHARE
Ghent, Belgium, 15 March 2010
top
Dicerna Signs Research Collaboration and License Agreement for Drug Delivery Systems and Dicer Substrate siRNA (DsiRNA) Pharmaceuticals with Kyowa Hakko Kirin
Watertown, Mass, 04 January 2010
top
|
Archive:
|
|||||||||||||||||||||||||||||||||
